Bionano Genomics, Inc. (BNGO) › Operating IncomeBionano Genomics, Inc. (BNGO) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2017: -$23.22M2018: -$20.42M2019: -$25.87M2020: -$38.55M2021: -$77.10M2022: -$131.70M2023: -$215.25M2024: -$103.98M2025: -$33.34M-$33.34M2017Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$33.34M+67.9%2024-$103.98M+51.7%2023-$215.25M-63.4%2022-$131.70M-70.8%2021-$77.10M-100.0%2020-$38.55M-49.0%2019-$25.87M-26.7%2018-$20.42M+12.1%2017-$23.22M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share